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Abstract 
Aims: Pulmonary regurgitation (PR) causes progressive right ventricle (RV) dilatation 
and dysfunction in repaired tetralogy of Fallot (rToF). Declining RV function is often 
insidious and the timing of pulmonary valve replacement remains under debate. 
Quantifying the pathophysiology of adverse RV remodelling due to worsening PR 
may help in defining the best timing for PVR. Our aim was to identify whether 
complex three-dimensional (3D) deformations of RV shape, as assessed with 
computer modelling, could constitute an anatomical biomarker that correlated with 
clinical parameters in rToF patients. 
 
Methods and Results: We selected 38 rToF patients (aged 10-30 years) who had 
complete datasets and had not undergone PVR from a population of 314 consecutive 
patients recruited in a collaborative study of four hospitals. All patients underwent 
cardiovascular magnetic resonance (CMR) imaging: PR and RV end-diastolic 
volumes were measured. An unbiased shape analysis framework was used with 
principal component analysis and linear regression to correlate shape with indexed 
PR volume. Regurgitation severity was significantly associated with RV dilatation 
(p=0.01) and associated with bulging of the outflow tract (p=0.07) and a dilatation of 
the apex (p=0.08). 
 
Conclusion: In this study, we related RV shape at end diastole to clinical metrics of 
PR in rToF patients. By considering the entire 3D shape, we identified a link between 
PR and RV dilatation, outflow tract bulging and apical dilatation. Our study 
constitutes a first attempt to correlate 3D RV shape with clinical metrics in rToF, 
opening new ways to better quantify 3D RV change in rToF. 
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Introduction 
Early surgical repair of tetralogy of Fallot often leaves patients with residual 
pulmonary regurgitation (PR), which is associated with significant late complications 
± exercise intolerance, right heart failure, arrhythmias and sudden death.1-3 
Pulmonary valve replacement (PVR)4,5 in repaired tetralogy of Fallot (rToF) has 
become the treatment of choice to treat late PR, and halt or at least slow down the 
progression of adverse right ventricular (RV) remodelling and its sequelae. 
Unfortunately, PVR is not a definitive therapeutic option and clinicians have to 
balance the immediate benefits of PVR against the likelihood of long-term 
complications and the need for future re-intervention. Accurate follow-up of patients 
is necessary, often with serial assessment of RV size and systolic function, using 
cardiovascular magnetic resonance (CMR) imaging;6-10 however, there are no clear, 
evidence-based guidelines on the optimal timing for PVR.11  
 
Computational modelling analysis of congenital heart disease,12 and in particular how 
RV dilatation evolves over time, could provide insights into pathological mechanisms, 
resulting in a useful support tool for disease evaluation and therapy planning. RV and 
RV outflow tract anatomy are complex and vary significantly among rToF patients13,14 
and therefore quantifying the entire RV shape is challenging. Recently, we have 
described a new method of computational modelling to analyze 3D shapes and 
compare them with clinical features for the RV.15 A few studies have partially 
analyzed the 3D alterations of the RV anatomy in rToF.16,17 Results from these 
studies suggest important differences in regional RV remodelling, but could not 
identify local changes in RV anatomy because the volume metrics used were too 
coarse.  
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In the present study, our aim was to investigate the clinical applicability of our 
computational modelling method. Assuming that RV shape can provide insight into 
the heart condition, we applied our shape analysis method to establish new 
quantitative metrics based on the RV shape that may assist in helping to plan when 
individual patients should undergo PVR. In particular, we aimed at identifying 
abnormal RV shape features that could reveal severe deterioration in the cardiac 
structure due to PR, which together with the clinical parameters may help in timing of 
PVR.  
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Methods 
Subjects 
As part of a collaborative study involving four hospitals (Gaslini Institute, Genoa, Italy; 
Great Ormond Street Hospital for Children, London, U.K.; Hôpital Necker ± Enfants 
Malades, Paris, France; %DPELQR*HV&KLOGUHQ¶V+RVSLWDO DQG5HVHDUFK ,QVWLWXWH, 
Rome, Italy;) every willing, consecutive patient with rToF was recruited over a 3-year 
period (n=314), as part of the FP6 Health-e-Child project (European project, IST-
2004-027749). Local ethical approval was given by all four hospitals for the research, 
and informed consent was received from the patients (and/or their legal guardians) to 
partake in the study.  
 
From the 314 patients enrolled into the Health-e-Child project, 49 had complete 
datasets that enabled them to be included in our current study (clinical features, 
echocardiogram, full CMR examination and right ventricle segmentation). These 
datasets were used to define a representative RV shape for the group. Subsequent 
analysis of shape and pulmonary regurgitation volume was carried out on the 38 
patients (26 males), from these 49 who had not undergone PVR prior to CMR. The 
majority of these patients (n=35) had had transannular surgery at their initial repair. 
Clinical features of these patients are reported in Table 1. Figure 1 summarizes the 
different steps of our analysis. 
 
Imaging assessment 
CMR exams were acquired with 1.5T MR scanners (Avanto, Siemens and Achieva, 
Philips). The standard approach to measure RV volume and function using cine 
imaging (balanced steady-state free precession sequences), with multiple short-axis 
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slices covering entirely both ventricles acquired during breath-holding (10-15 slices; 
in-plane resolution: 1.1 to 1.7 mm2; slice thickness: 5 to 8 mm; 25 to 40 phases). 
Manual tracking of the endocardial contours allowed the measurement of EDV, ESV, 
stroke volume (SV) and RV ejection fraction (EF). Flow quantification was performed 
using through-plane phase contrast velocity mapping, with a retrospectively gated, 
gradient echo sequence, during free respiration technique (slice thickness 8 mm, TE 
2.7 ms, TR 4.7 ms, acquisition matrix 176 x 512). Pulmonary regurgitant fraction 
(PRF) was calculated as pulmonary retrograde flow (mL/beat) x 100/pulmonary 
forward flow (mL/beat). Then pulmonary regurgitant volume (PRV) was indexed for 
BSA to give PRVi. 
 
Surface Mesh Preparation  
We studied the RV shape at end-diastole, when the anatomical features of the 
pathology are more pronounced.16 The RV endocardium was segmented on the end-
diastolic CMR cine images by fitting an anatomically accurate geometrical model.18 In 
brief, RV position, orientation, scale and boundaries in the images were determined 
automatically using machine-learning algorithms based on marginal space learning 
and probabilistic boosting tree. An expert manually adjusted the automatic fitting 
whenever it was necessary (Figure 2, left panel). At the end of the process, 3D 
meshes of the RV were available for every patient (Figure 2, mid-panel). In the 
subsequent text, we refer to these meshes as shapes. To avoid any bias in the 
statistical analyses due to patient positioning, the 3D meshes were rigidly aligned in a 
common coordinate system using a standard least-square method.19 
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RV Shape Representation and Quantification  
Right ventricles were investigated by analyzing how an ideal reference shape ± the 
template (developed from the 49 patients) ± deforms in a population of shapes ± here 
the set of RV meshes computed from the CMR data of our patients. Intuitively, if the 
template is deformed in such a way that it matches the RV shape of a patient, then 
the deformation that is applied encodes the shape information of that patient. A 
rigorous mathematical framework can then be employed on the non-linear 
deformations to analyze the shapes.20 Although any RV shape can be taken as the 
reference, to avoid any bias in the analysis, it is highly recommended to use a 
template that is as independent as possible from the studied population and that is 
µFHQWUHG¶± i.e. equally distant to all subjects. In this study, we estimated the template 
using the method proposed by Durrleman et al.20 Indeed, we have demonstrated in 
our previous study15 that the resulting template is robust with respect to rToF 
subjects and is well centred, thus constituting a suitable reference. Our computer 
modelling process is as follows:  We start from a template (the mean shape, 
represented by mathematical currents ± see20,21). We then compute the 
transformations that deform this template to the RV shapes of our patients.21 Using 
these transformations, we update the template such that it minimizes the residual 
errors of the template-to-patient matching. We repeat these two steps iteratively until 
convergence. At the end of the process, we obtain an unbiased template of the RV 
and the related deformations. It can be observed that in such a framework, the 
template and the deformations are calculated simultaneously, a key requirement for a 
consistent shape analysis (see15,20,21 for mathematical details). It should be stressed 
that the computed template is an ideal geometry representing the average RV 
observed in the population. As such, no clinical data is available for this template. In 
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rather represents the entire population under study. 
 
Compact Representation of Patient RV Shape 
The non-linear deformations computed in the previous step, which encode patient RV 
shapes, make it possible to quantitatively correlate RV shape with clinical variables. 
However, direct statistics on these deformations was not possible as they were 
represented by too many parameters (>1000) to have a good statistical power. To 
reduce the dimensionality of the problem, we thus performed a principal component 
analysis (PCA) of the deformations (see15,20). The 38 patients under study were used 
to compute the principal components of the deformations. The PCA modes, called 
deformation modes, represented a specific pattern of RV shape variation observed in 
this population (e.g. overall dilatation, apical bulging, etc.). Since this pattern is 
computed from the entire population, it is not related to specific clinical data or CMR 
images. By projecting patient deformations into the PCA space, we could represent 
each patient by a low-dimensional shape vector whose elements quantified the 
contribution of each deformation mode in patient RV shape. In other words, by 
definition of the PCA, the RV shape of a given patient is the weighted sum of all 
computed deformation modes, the weights varying from patient to patient. As the 
number of elements of the shape vector was lower than the number of patients, 
standard statistical designs could be applied to quantitatively correlate the RV 
features identified by the PCA modes with clinical features. 
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Identification of Pathological Shape Features 
To identify shape features related to regurgitation, we related the shape vectors to 
indexed PR volume (PRVi) using linear regression with automatic model reduction 
according to Akaike Information Criterion. We used indexed measurements to 
remove growth effects from the analysis. The idea was to estimate a reduced linear 
model that predicted the PRVi (measured variable) from the elements of the shape 
vectors (predictors). The deformation modes corresponding to the elements selected 
in the model encoded the 3D shape features that were related to PRVi, which we 
could visualize and quantify by deforming the reference template with these 
deformation modes. The sign of the linear regression coefficients identified the 
direction of correlation along the deformation mode for increasing PRVi. All the tests 
were performed with R (R Development Core Team, 2009). The level of significance 
was set at p<0.05. 
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Results 
Template of the Right Ventricle  
Figure 2, left-panel shows a 3D RV mesh overlaid on the CMR image of a patient. 
Figure 2, mid-panel illustrates the RV meshes of all patients aligned in a common 
coordinate system. Since the overall study was retrospective, only 49 patients out of 
314 had complete CMR data. To avoid any bias we thus computed the template 
using all available patients. Figure 2, right panel illustrates the RV template estimated 
from the 49 patients. The template was well centred with respect to the population, 
as quantified by the standardized mean of deformations, mean/sd = 0.4 < 1). 
,QWHUHVWLQJO\WKHSDWLHQW¶VDJHWKDWZDVFORVHVWWRWKHWHPSODWHZDV16 years whose 
BSA was 1.64 m2. Both values were close to population average (Table 1), which 
suggests a good consistency between the template and the above-mentioned clinical 
features. 
 
Relating the Right Ventricle Shape to Pulmonary Regurgitation 
Twenty deformation modes encoded 95% of shape variability observed in our 
population who had not undergone PVR (n=38), resulting in 20-element shape 
vectors. The optimal linear model consisted of six PCA modes (Table 2) (R2 = 0.39, p 
= 0.013). Three deformation modes were found statistically relevant to the model. 
Mode 1 was significantly and positively related to increasing PRVi (p=0.01), whilst 
there was a positive association with Mode 12 (p=0.07) and a negative association 
with mode 15 (p=0.08). Applying these deformation modes onto the template enabled 
us to visualize and quantify the shape changes. From Figure 3, we observed that in 
our population, PRVi is related to RV global enlargement (mode 1), bulging of the 
outflow tract towards an aneurismal shape (mode 12 and 15), dilatation of the RV 
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apex (mode 12 and 15), dilatation of the pulmonary valve annulus and a more 
circular tricuspid valve.  These findings are consistent with previous results on a 
different population.15,22 
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Discussion 
To the best of our knowledge, this study constitutes a first attempt to correlate 3D RV 
shape with clinical parameters in patients with rToF using computer modelling. We 
have shown in a realistic way that the RV dilates (the outlet bulges and the apex 
deforms) as pulmonary regurgitation volume worsens. Due to the fact that our 
approach considers the complete 3D shape on a regional level, it could constitute a 
useful tool for the management of rToF patients by providing quantitative features of 
RV shape that are more discriminating compared to standard CMR analysis, which 
relies only on the volume. 
 
While our findings are relatively known and our work is similar to Sheehan et al., 
2008,16 our approach is radically different and opens new avenues in the shape 
analysis of the cardiac chambers. While Sheehan et al. analyzed specific lumped 
markers from the 3D shape, we assess the entire 3D shape analyzed directly, 
without the introduction of any prior knowledge, which is implicitly the case when 
selecting specific metrics. As a result, we can now identify more subtle features that 
cannot be encoded by lumped metrics easily. The features related to PR are 
automatically extracted by the correlation analysis. It is therefore interesting to see 
that we can recover the main features of rToF using our approach.  
 
Though RV volume is one of the outcome predictors in rToF patients, chamber 
geometry, myofiber architecture, RV compliance, chamber contraction pattern and 
the interdependence between LV and RV function are likely to play a role in defining 
the long-term outcomes for rToF patients. In addition, any RV outflow tract patch and 
the consequent localized fibrosis and akinesis/dyskinesis of the RV outflow tract, 
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which vary from patient to patient, may play a role in pathophysiology.23 Assessment 
of the RV outflow tract remains difficult on both CMR and echo24,25 and an overall 3D 
assessment of RV shape may prove to be a useful biomarker. The methods we 
describe could give us a more realistic and complete view of 3D RV shape, which 
may give further insight into the timing of PVR, though larger scale studies to assess 
the usefulness of such a new biomarker would need to be performed. Importantly, 
though our method has been developed using CMR data, it could be applied to 3D 
echo data, to act as a surrogate for pulmonary regurgitation severity. As semi-
automatic or fully automatic methods are available to segment the heart on echo 
images, the resulting meshes could then be directly used in our framework to extract 
shape features. Other functional parameters, such as Doppler flow metrics or strain 
could also be included in the statistical analysis for a more comprehensive correlation 
between shape and function.  
 
Although there is strong evidence that PVR is safe and effective at eliminating or 
greatly reducing pulmonary regurgitation, it should be kept in mind that in the majority 
of studies global RV systolic function remains unchanged. Moreover, at present, data 
regarding the effects of PVR on arrhythmia propensity and objective exercise 
parameters are inconsistent. Therefore, having additional information may be useful 
for defining patient outcomes. In addition, our model can be useful to quantify the 
degree of bulging by computing the RV shape vector of a patient, an index that could 
be used as a predictor of PVR. Thus, it could be helpful not only to facilitate the 
decision on the right timing and type of surgical approach, but also to monitor the 
effect of chronic pulmonary regurgitation and, consequently, the volume load on RV 
mechanics during the life of a specific rToF patient.  
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In the future, we could perform analysis with BSA, patient age15, and gender26 to 
understand how RV shape changes in relation to growth, and use such models to 
predict the pulmonary regurgitant volume over time. Deviation from what is known to 
EH WKH µQRUPDO¶ SUHGLFWHd RV shape change for any given individual patient might 
alert us to sub-clinical deterioration in RV function that could trigger closer clinical 
follow-up or even early PVR. Whilst patients who are doing better than expected may 
be able to have PVR deferred. Furthermore, analysis of the LV-RV interaction by 
directly applying our segmentation and shape methodology of the bi-ventricular 
myocardium could provide further novel information. Finally, our approach might also 
be applied on post-operative data to study the long-term impact of new PVR 
therapies on RV anatomy.27,28  
 
Limitations: A drawback of this study is the lack of control subjects that, 
unfortunately, prevented us from studying the differences between rToF patients and 
healthy subjects, as in the study of Zhang et al.29 Furthermore, we have analysed a 
relatively small number of patients to estimate the template, as CMR data was not 
available retrospectively in all patients recruited for the Health-e-Child study. Future 
work should include the analysis of a larger population to confirm our findings. 
 
Conclusions: We have provided new insights into the mechanical adaptation of RV 
to chronic significant pulmonary insufficiency in rToF patients. The measurement of 
an RV shape biomarker may allow for personalized follow-up of rToF patient, which 
may help defining the timing of PVR.  
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Tables 
 
Table 1: Clinical features of 38 rToF patients (mean ± standard deviation).  
 
 
 
Table 2: Regression coefficients between the shape vectors and PRVi after model 
reduction (R2 = 0.39, P = 0.013). Six modes were kept. The sign of the coefficients 
indicates the direction of correlation for increasing PRVi. In bold the modes that were 
relevant to PRVi. 
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38 patients with rToF 
Age  16.34 ± 4.38 year 
Body surface area 1.56 ± 0.36 m2 
Pulmonary regurgitant fraction (PRF) 43.32 ± 11.77 % 
Indexed pulmonary regurgitant volume 
(PRVi) 
31.79 ± 15.73 mL/beat/m2 
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Figures 
Figure 1: Analysis pipeline. The RV were first segmented from cardiac MRI. A 
reference template and the deformations, which mapped that template to each RV, 
were then computed to quantify RV shapes. PCA on deformations was performed to 
extract the main shape variation features and reduce model dimension. Linear 
regression was finally estimated to identify the shape features related to PRVi. See 
text for details. 
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Figure 2: Left panel: 3D RV mesh of a patient overlaid on its CMR. Mid panel: 3D RV meshes of 49 patients segmented from CMR 
and rigidly aligned to a common coordinate frame. Observe the large variability in shape. Right panel: Mean RV shape of the 
population 
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Figure 3: Variations in RV shape correlated with PRVi in 38 patients. Modes 1, 12 
and 15 were found significantly related to PRVi.  
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